TriSalus Life Sciences (TLSI) Cost of Revenue (2022 - 2025)
Historic Cost of Revenue for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $6.8 million.
- TriSalus Life Sciences' Cost of Revenue rose 1142.07% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 1355.95%. This contributed to the annual value of $25.8 million for FY2024, which is 5169.07% up from last year.
- Per TriSalus Life Sciences' latest filing, its Cost of Revenue stood at $6.8 million for Q3 2025, which was up 1142.07% from $7.2 million recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Cost of Revenue ranged from a high of $7.2 million in Q2 2025 and a low of $3.0 million during Q3 2022
- Moreover, its 4-year median value for Cost of Revenue was $6.0 million (2024), whereas its average is $5.4 million.
- Per our database at Business Quant, TriSalus Life Sciences' Cost of Revenue surged by 10581.72% in 2024 and then surged by 70.29% in 2025.
- TriSalus Life Sciences' Cost of Revenue (Quarter) stood at $3.9 million in 2022, then skyrocketed by 45.29% to $5.6 million in 2023, then increased by 25.09% to $7.0 million in 2024, then decreased by 2.44% to $6.8 million in 2025.
- Its Cost of Revenue was $6.8 million in Q3 2025, compared to $7.2 million in Q2 2025 and $6.7 million in Q1 2025.